Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target

Biochemical Pharmacology

Volumn 94, Issue 1, 2015, Pages 1-11

  Radogna, Flavia ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Anti cancer therapy; Apoptosis; Autophagy; Cancer; Chemoprevention; Necroptosis; Personalized treatment

Indexed keywords

CURCUMIN; GOSSYPOL; INHIBITOR OF APOPTOSIS PROTEIN; OBATOCLAX; PACLITAXEL; PEPTIDOMIMETIC AGENT; PROTEIN BCL 2; PROTEINASE; QUERCETIN; RESVERATROL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TARGET OF RAPAMYCIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MTOR PROTEIN, HUMAN; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER THERAPY; CELL DEATH; DRUG MECHANISM; DRUG TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANTIBODY SPECIFICITY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NECROSIS; NEOPLASMS; PATHOLOGY; PERSONALIZED MEDICINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIVIDUALIZED MEDICINE; MEMBRANE PROTEINS; NECROSIS; NEOPLASMS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84922736742     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.12.018     Document Type: Note

References (141)

1. Y. Kondo, T. Kanzawa, R. Sawaya, and S. Kondo The role of autophagy in cancer development and response to therapy Nat Rev Cancer 5 2005 726 734
2. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
3. A. Degterev, M. Boyce, and J. Yuan A decade of caspases Oncogene 22 2003 8543 8567
4. C.A. Schmitt, and S.W. Lowe Apoptosis and therapy J Pathol 187 1999 127 137
5. B. Mayer, and R. Oberbauer Mitochondrial regulation of apoptosis News Physiol Sci 18 2003 89 94
6. C. Brenner, and S. Grimm The permeability transition pore complex in cancer cell death Oncogene 25 2006 4744 4756
7. J.E. Chipuk, and D.R. Green How do BCL-2 proteins induce mitochondrial outer membrane permeabilization' Trends Cell Biol 18 2008 157 164
8. H.L. Galonek, and J.M. Hardwick Upgrading the BCL-2 network Nat Cell Biol 8 2006 1317 1319
9. L. Ghibelli, and M. Diederich Multistep and multitask Bax activation Mitochondrion 10 2010 604 613
10. G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilization in cell death Physiol Rev 87 2007 99 163
11. S. Fulda, and K.M. Debatin Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy Oncogene 25 2006 4798 4811
12. H. Walczak, and P.H. Krammer The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp Cell Res 256 2000 58 66
13. T. Kaufmann, A. Strasser, and P.J. Jost Fas death receptor signalling: roles of Bid and XIAP Cell Death Differ 19 2012 42 50
14. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
15. C. Brenner, H. Cadiou, H.L. Vieira, N. Zamzami, I. Marzo, and Z. Xie Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator Oncogene 19 2000 329 336
16. S. Shimizu, Y. Shinohara, and Y. Tsujimoto Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator Oncogene 19 2000 4309 4318
17. J. Michels, O. Kepp, L. Senovilla, D. Lissa, M. Castedo, and G. Kroemer Functions of BCL-X L at the interface between cell death and metabolism Int J Cell Biol 2013 2013 705294
18. N.N. Danial, C.F. Gramm, L. Scorrano, C.Y. Zhang, S. Krauss, and A.M. Ranger BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis Nature 424 2003 952 956
19. M.C. Maiuri, G. Le Toumelin, A. Criollo, J.C. Rain, F. Gautier, and P. Juin Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1 Embo J 26 2007 2527 2539
20. M.C. Maiuri, A. Criollo, E. Tasdemir, J.M. Vicencio, N. Tajeddine, and J.A. Hickman BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L) Autophagy 3 2007 374 376
21. T. Vanden Berghe, N. Vanlangenakker, E. Parthoens, W. Deckers, M. Devos, and N. Festjens Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features Cell Death Differ 17 2010 922 930
22. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer Molecular mechanisms of necroptosis: an ordered cellular explosion Nat Rev Mol Cell Biol 11 2010 700 714
23. D.E. Christofferson, and J. Yuan Necroptosis as an alternative form of programmed cell death Curr Opin Cell Biol 22 2010 263 268
24. N. Vanlangenakker, T. Vanden Berghe, and P. Vandenabeele Many stimuli pull the necrotic trigger, an overview Cell Death Differ 19 2012 75 86
25. N. Holler, R. Zaru, O. Micheau, M. Thome, A. Attinger, and S. Valitutti Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nat Immunol 1 2000 489 495
26. D.W. Zhang, J. Shao, J. Lin, N. Zhang, B.J. Lu, and S.C. Lin RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis Science 325 2009 332 336
27. L.S. Dickens, I.R. Powley, M.A. Hughes, and M. MacFarlane The 'complexities' of life and death: death receptor signalling platforms Exp Cell Res 318 2012 1269 1277
28. S. Lacour, O. Micheau, A. Hammann, V. Drouineaud, J. Tschopp, and E. Solary Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells Oncogene 22 2003 1807 1816
29. K. Bianchi, and P. Meier A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling Mol Cell 36 2009 736 742
30. A. Devin, A. Cook, Y. Lin, Y. Rodriguez, M. Kelliher, and Z. Liu The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation Immunity 12 2000 419 429
31. M.J. Bertrand, S. Milutinovic, K.M. Dickson, W.C. Ho, A. Boudreault, and J. Durkin cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination Mol Cell 30 2008 689 700
32. W.W. Reiley, W. Jin, A.J. Lee, A. Wright, X. Wu, and E.F. Tewalt Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses J Exp Med 204 2007 1475 1485
33. O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp, and D.W. Nicholson The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex J Biol Chem 277 2002 45162 45171
34. Y.T. Wu, H.L. Tan, Q. Huang, X.J. Sun, X. Zhu, and H.M. Shen zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway Cell Death Differ 18 2011 26 37
35. H. Zhang, X. Zhou, T. McQuade, J. Li, F.K. Chan, and J. Zhang Functional complementation between FADD and RIP1 in embryos and lymphocytes Nature 471 2011 373 376
36. H. Shiraishi, H. Okamoto, H. Hara, and H. Yoshida Alternative cell death of Apaf1-deficient neural progenitor cells induced by withdrawal of EGF or insulin Biochim Biophys Acta 1800 2010 405 415
37. M. Leist, B. Single, A.F. Castoldi, S. Kuhnle, and P. Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J Exp Med 185 1997 1481 1486
38. R.A. Lockshin, and Z. Zakeri Programmed cell death and apoptosis: origins of the theory Nat Rev Mol Cell Biol 2 2001 545 550
39. S. Shimizu, T. Kanaseki, N. Mizushima, T. Mizuta, S. Arakawa-Kobayashi, and C.B. Thompson Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nat Cell Biol 6 2004 1221 1228
40. D. Denton, T. Xu, and S. Kumar Autophagy as a pro-death pathway Immunol Cell Biol 93 2015 35 42
41. D.L. Berry, and E.H. Baehrecke Autophagy functions in programmed cell death Autophagy 4 2008 359 360
42. M.C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer Self-eating and self-killing: crosstalk between autophagy and apoptosis Nat Rev Mol Cell Biol 8 2007 741 752
43. S. Shen, O. Kepp, and G. Kroemer The end of autophagic cell death' Autophagy 8 2012 1 3
44. H.M. Shen, and P. Codogno Autophagic cell death: Loch Ness monster or endangered species' Autophagy 7 2011 457 465
45. J.J. Lum, D.E. Bauer, M. Kong, M.H. Harris, C. Li, and T. Lindsten Growth factor regulation of autophagy and cell survival in the absence of apoptosis Cell 120 2005 237 248
46. R.K. Amaravadi, and C.B. Thompson The roles of therapy-induced autophagy and necrosis in cancer treatment Clin Cancer Res 13 2007 7271 7279
47. Y.T. Wu, H.L. Tan, Q. Huang, Y.S. Kim, N. Pan, and W.Y. Ong Autophagy plays a protective role during zVAD-induced necrotic cell death Autophagy 4 2008 457 466
48. J.Y. Guo, H.Y. Chen, R. Mathew, J. Fan, A.M. Strohecker, and G. Karsli-Uzunbas Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis Genes Dev 25 2011 460 470
49. K. Degenhardt, R. Mathew, B. Beaudoin, K. Bray, D. Anderson, and G. Chen Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis Cancer Cell 10 2006 51 64
50. B. Levine, N. Mizushima, and H.W. Virgin Autophagy in immunity and inflammation Nature 469 2011 323 335
51. B. Levine, and D.J. Klionsky Development by self-digestion: molecular mechanisms and biological functions of autophagy Dev Cell 6 2004 463 477
52. N. Mizushima, B. Levine, A.M. Cuervo, and D.J. Klionsky Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075
53. M. Castedo, K.F. Ferri, and G. Kroemer Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic Cell Death Differ 9 2002 99 100
54. Y. Ichimura, T. Kirisako, T. Takao, Y. Satomi, Y. Shimonishi, and N. Ishihara A ubiquitin-like system mediates protein lipidation Nature 408 2000 488 492
55. N. Mizushima, T. Noda, and Y. Ohsumi Apg16p is required for the function of the Apg12p-Apg5p conjugate in the yeast autophagy pathway Embo J 18 1999 3888 3896
56. V. Kaminskyy, and B. Zhivotovsky Proteases in autophagy Biochim Biophys Acta 1824 2012 44 50
57. R. Kang, H.J. Zeh, M.T. Lotze, and D. Tang The Beclin 1 network regulates autophagy and apoptosis Cell Death Differ 18 2011 571 580
58. X.H. Liang, L.K. Kleeman, H.H. Jiang, G. Gordon, J.E. Goldman, and G. Berry Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein J Virol 72 1998 8586 8596
59. A. Oberstein, P.D. Jeffrey, and Y. Shi Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein J Biol Chem 282 2007 13123 13132
60. C. He, and B. Levine The Beclin 1 interactome Curr Opin Cell Biol 22 2010 140 149
61. Y. Zhu, S. Massen, M. Terenzio, V. Lang, S. Chen-Lindner, and R. Eils Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis J Biol Chem 288 2013 1099 1113
62. S. Huang, and F.A. Sinicrope Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells Mol Cancer Ther 9 2010 742 750
63. E. Wirawan, L. Vande Walle, K. Kersse, S. Cornelis, S. Claerhout, and I. Vanoverberghe Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria Cell Death Dis 1 2010 e18
64. A.D. Rubinstein, M. Eisenstein, Y. Ber, S. Bialik, and A. Kimchi The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis Mol Cell 44 2011 698 709
65. L. Radoshevich, and J. Debnath ATG12-ATG3 and mitochondria Autophagy 7 2011 109 111
66. L. Radoshevich, L. Murrow, N. Chen, E. Fernandez, S. Roy, and C. Fung ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death Cell 142 2010 590 600
67. S. Yousefi, R. Perozzo, I. Schmid, A. Ziemiecki, T. Schaffner, and L. Scapozza Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis Nat Cell Biol 8 2006 1124 1132
68. H. Wu, X. Che, Q. Zheng, A. Wu, K. Pan, and A. Shao Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis Int J Biol Sci 10 2014 1072 1083
69. O. Oral, D. Oz-Arslan, Z. Itah, A. Naghavi, R. Deveci, and S. Karacali Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death Apoptosis 17 2012 810 820
70. V.M. Betin, and J.D. Lane Atg4D at the interface between autophagy and apoptosis Autophagy 5 2009 1057 1059
71. S. Orozco, N. Yatim, M.R. Werner, H. Tran, S.Y. Gunja, and S.W. Tait RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis Cell Death Differ 21 2014 1511 1521
72. L. Duprez, M.J. Bertrand, T. Vanden Berghe, Y. Dondelinger, N. Festjens, and P. Vandenabeele Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis J Biol Chem 287 2012 14863 14872
73. Y. Lin, A. Devin, Y. Rodriguez, and Z.G. Liu Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis Genes Dev 13 1999 2514 2526
74. B.D. Bell, and C.M. Walsh Coordinate regulation of autophagy and apoptosis in T cells by death effectors: FADD or foundation Autophagy 5 2009 238 240
75. J.O. Pyo, M.H. Jang, Y.K. Kwon, H.J. Lee, J.I. Jun, and H.N. Woo Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death J Biol Chem 280 2005 20722 20729
76. B.D. Bell, S. Leverrier, B.M. Weist, R.H. Newton, A.F. Arechiga, and K.A. Luhrs FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells Proc Natl Acad Sci USA 105 2008 16677 16682
77. G. Kroemer, and M. Jaattela Lysosomes and autophagy in cell death control Nat Rev Cancer 5 2005 886 897
78. M. Hoyer-Hansen, and M. Jaattela Autophagy: an emerging target for cancer therapy Autophagy 4 2008 574 580
79. T. Kirkegaard, and M. Jaattela Lysosomal involvement in cell death and cancer Biochim Biophys Acta 1793 2009 746 754
80. N. Fehrenbacher, and M. Jaattela Lysosomes as targets for cancer therapy Cancer Res 65 2005 2993 2995
81. M.M. Young, Y. Takahashi, O. Khan, S. Park, T. Hori, and J. Yun Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis J Biol Chem 287 2012 12455 12468
82. M.A. Laussmann, E. Passante, H. Dussmann, J.A. Rauen, M.L. Wurstle, and M.E. Delgado Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8 Cell Death Differ 18 2011 1584 1597
83. Z. Jin, Y. Li, R. Pitti, D. Lawrence, V.C. Pham, and J.R. Lill Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling Cell 137 2009 721 735
84. H. Jiang, E.J. White, C.I. Rios-Vicil, J. Xu, C. Gomez-Manzano, and J. Fueyo Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity J Virol 85 2011 4720 4729
85. M. Feoktistova, P. Geserick, B. Kellert, D.P. Dimitrova, C. Langlais, and M. Hupe cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms Mol Cell 43 2011 449 463
86. T. Tenev, K. Bianchi, M. Darding, M. Broemer, C. Langlais, and F. Wallberg The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs Mol Cell 43 2011 432 448
87. S.M. Kavuri, P. Geserick, D. Berg, D.P. Dimitrova, M. Feoktistova, and D. Siegmund Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex J Biol Chem 286 2011 16631 16646
88. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9 22
89. M.N. Corradetti, and K.L. Guan Upstream of the mammalian target of rapamycin: do all roads pass through mTOR' Oncogene 25 2006 6347 6360
90. B.G. Wouters, and M. Koritzinsky Hypoxia signalling through mTOR and the unfolded protein response in cancer Nat Rev Cancer 8 2008 851 864
91. M. Germain, A.P. Nguyen, J.N. Le Grand, N. Arbour, J.L. Vanderluit, and D.S. Park MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner Embo J 30 2011 395 407
92. C. Cerella, M.H. Teiten, F. Radogna, M. Dicato, and M. Diederich From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment Biotechnol Adv 32 2014 1111 1122
93. C. Cerella, F. Radogna, M. Dicato, and M. Diederich Natural compounds as regulators of the cancer cell metabolism Int J Cell Biol 2013 2013 639401
94. B. Orlikova, and M. Diederich Power from the garden: plant compounds as inhibitors of the hallmarks of cancer Curr Med Chem 19 2012 2061 2087
95. C. Florean, and M. Diederich Redox regulation: natural compound as regulators of inflammation signaling Biochem Pharmacol 84 2012 1223 1224
96. Y. Meng, W. Tang, Y. Dai, X. Wu, M. Liu, and Q. Ji Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa Mol Cancer Ther 7 2008 2192 2202
97. C. Bodur, and H. Basaga Bcl-2 inhibitors: emerging drugs in cancer therapy Curr Med Chem 19 2012 1804 1820
98. L. Yu, and S. Liu Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics Semin Cancer Biol 23 2013 553 560
99. J. Lian, D. Karnak, and L. Xu The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells Autophagy 6 2010 1201 1203
100. J. Lian, X. Wu, F. He, D. Karnak, W. Tang, and Y. Meng A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum Cell Death Differ 18 2011 60 71
101. G.H. Jang, and M. Lee BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip(1) Life Sci 102 2014 41 48
102. V. Voss, C. Senft, V. Lang, M.W. Ronellenfitsch, J.P. Steinbach, and V. Seifert The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma Mol Cancer Res 8 2010 1002 1016
103. P. Gao, C. Bauvy, S. Souquere, G. Tonelli, L. Liu, and Y. Zhu The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells J Biol Chem 285 2010 25570 25581
104. L. Moretti, B. Li, K.W. Kim, H. Chen, and B. Lu AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer J Thorac Oncol 5 2010 680 687
105. N. Ready, N.A. Karaseva, S.V. Orlov, A.V. Luft, O. Popovych, and J.T. Holmlund Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer J Thorac Oncol 6 2011 781 785
106. J. Joudeh, and D. Claxton Obatoclax mesylate: pharmacology and potential for therapy of hematological neoplasms Expert Opin Investig Drugs 21 2012 363 373
107. A. Sharma, K. Singh, S. Mazumder, B.T. Hill, M. Kalaycio, and A. Almasan BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells Cell Death Dis 4 2013 e628
108. A. Hosseini, M. Espona-Fiedler, V. Soto-Cerrato, R. Quesada, R. Perez-Tomas, and V. Guallar Molecular interactions of prodiginines with the BH3 domain of anti-apoptotic Bcl-2 family members PLoS One 8 2013 e57562
109. F. Basit, S. Cristofanon, and S. Fulda Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes Cell Death Differ 20 2013 1161 1173
110. L. Bonapace, B.C. Bornhauser, M. Schmitz, G. Cario, U. Ziegler, and F.K. Niggli Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance J Clin Invest 120 2010 1310 1323
111. S. Trudel, Z.H. Li, J. Rauw, R.E. Tiedemann, X.Y. Wen, and A.K. Stewart Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma Blood 109 2007 5430 5438
112. A.A. Chiappori, M.T. Schreeder, M.M. Moezi, J.J. Stephenson, J. Blakely, and R. Salgia A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer Br J Cancer 106 2012 839 845
113. D. Merino, N. Lalaoui, A. Morizot, E. Solary, and O. Micheau TRAIL in cancer therapy: present and future challenges Expert Opin Ther Targets 11 2007 1299 1314
114. S. Jouan-Lanhouet, M.I. Arshad, C. Piquet-Pellorce, C. Martin-Chouly, G. Le Moigne-Muller, and F. Van Herreweghe TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation Cell Death Differ 19 2012 2003 2014
115. A. Ashkenazi, P. Holland, and S.G. Eckhardt Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) J Clin Oncol 26 2008 3621 3630
116. H. Hetschko, V. Voss, V. Seifert, J.H. Prehn, and D. Kogel Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis FEBS J 275 2008 1925 1936
117. V. Pavet, M.M. Portal, J.C. Moulin, R. Herbrecht, and H. Gronemeyer Towards novel paradigms for cancer therapy Oncogene 30 2011 1 20
118. S.A. Rushworth, and O. Micheau Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer Br J Pharmacol 157 2009 1186 1188
119. Q.L. Deveraux, R. Takahashi, G.S. Salvesen, and J.C. Reed X-linked IAP is a direct inhibitor of cell-death proteases Nature 388 1997 300 304
120. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
121. B.A. Abhari, S. Cristofanon, R. Kappler, D. von Schweinitz, R. Humphreys, and S. Fulda RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex Oncogene 32 2013 3263 3273
122. P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe The role of the kinases RIP1 and RIP3 in TNF-induced necrosis Sci Signal 3 2010 re4
123. B. Laukens, C. Jennewein, B. Schenk, N. Vanlangenakker, A. Schier, and S. Cristofanon Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor alpha-induced necroptosis Neoplasia 13 2011 971 979
124. L. Steinhart, K. Belz, and S. Fulda Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis Cell Death Dis 4 2013 e802
125. J.W. Park, Y.J. Choi, M.A. Jang, Y.S. Lee, D.Y. Jun, and S.I. Suh Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells Cancer Lett 163 2001 43 49
126. A.W. Opipari Jr., L. Tan, A.E. Boitano, D.R. Sorenson, A. Aurora, and J.R. Liu Resveratrol-induced autophagocytosis in ovarian cancer cells Cancer Res 64 2004 696 703
127. J.W. Park, Y.J. Choi, S.I. Suh, W.K. Baek, M.H. Suh, and I.N. Jin Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity Carcinogenesis 22 2001 1633 1639
128. F. Scarlatti, R. Maffei, I. Beau, P. Codogno, and R. Ghidoni Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells Cell Death Differ 15 2008 1318 1329
129. A. Duvoix, R. Blasius, S. Delhalle, M. Schnekenburger, F. Morceau, and E. Henry Chemopreventive and therapeutic effects of curcumin Cancer Lett 223 2005 181 190
130. S. Reuter, S. Eifes, M. Dicato, B.B. Aggarwal, and M. Diederich Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells Biochem Pharmacol 76 2008 1340 1351
131. D. Kang, W. Park, S. Lee, J.H. Kim, and J.J. Song Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment Cell Signal 25 2013 1288 1300
132. S.V. Bava, V.T. Puliappadamba, A. Deepti, A. Nair, D. Karunagaran, and R.J. Anto Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization J Biol Chem 280 2005 6301 6308
133. S. Aggarwal, H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation Mol Pharmacol 69 2006 195 206
134. J.H. Woo, Y.H. Kim, Y.J. Choi, D.G. Kim, K.S. Lee, and J.H. Bae Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 24 2003 1199 1208
135. C.S. Beevers, F. Li, L. Liu, and S. Huang Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells Int J Cancer 119 2006 757 764
136. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B.B. Aggarwal, and Y. Kondo Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways Mol Pharmacol 72 2007 29 39
137. Y.J. Lee, N.Y. Kim, Y.A. Suh, and C. Lee Involvement of ROS in curcumin-induced autophagic cell death Korean J Physiol Pharmacol 15 2011 1 7
138. R. Wessely, A. Schomig, and A. Kastrati Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different J Am Coll Cardiol 47 2006 708 714
139. G.M. Ajabnoor, T. Crook, and H.M. Coley Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells Cell Death Dis 3 2012 e260
140. K. Wang, R. Liu, J. Li, J. Mao, Y. Lei, and J. Wu Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1alpha-mediated signaling Autophagy 7 2011 966 978
141. G.L. Russo, M. Russo, C. Spagnuolo, I. Tedesco, S. Bilotto, and R. Iannitti Quercetin: a pleiotropic kinase inhibitor against cancer Cancer Treat Res 159 2014 185 205